Celia Salazar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Celia Salazar has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Alvaro A. Elorza
Institute of Biomedical Sciences, Faculty of Medicine and Faculty of Life Sciences, Universidad Andres Bello, Santiago 8370071, Chile
1 shared publication - Erik L. Jensen
Aix Marseille Univ, CNRS, BIP, UMR 7281, IMM, FR 3479, 31 Chemin J. Aiguier, CEDEX 20, 13 402 Marseille, France
1 shared publication - Lina Maria Ruiz
Institute of Biomedical Sciences, Faculty of Health Sciences, Universidad Autónoma de Chile, Santiago 8910060, Chile
1 shared publication Marlen Barreto
Center of Biomedical Research, Faculty of Health Sciences, Universidad Autónoma de Chile, Ricardo Morales 3369, 8910132 Santiago, Chile
1 shared publicationPaula A. Ruiz
Eng Solutions Ltd., London N12 0DR, UK
1 shared publication- Rodrigo A. Quintanilla
Laboratory of Neurodegenerative Diseases, Instituto de Ciencias Biomédicas, Facultad de Ciencias de La Salud, Universidad Autónoma de Chile, Santiago, Chile
1 shared publication
Latest Publications
- Open Access
- 1 January 2015
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2015, 1-12
Quercetin Affects Erythropoiesis and Heart Mitochondrial Function in Mice
Quercetin, a dietary flavonoid used as a food supplement, showed powerful antioxidant effects in different cellular models. However, recentin vitroandin vivostudies in mammals have suggested a prooxidant effect of quercetin and described an interaction with mitochondria causing an increase inproduction, a decrease in ATP levels, and impairment of respiratory chain in liver tissue. Therefore, because of its dual actions, we studied the effect of quercetinin vivoto analyze heart mitochondrial function and erythropoiesis. Mice were injected with 50 mg/kg of quercetin for 15 days. Treatment with quercetin decreased body weight, serum insulin, and ceruloplasmin levels as compared with untreated mice. Along with an impaired antioxidant capacity in plasma, quercetin-treated mice showed a significant delay on erythropoiesis progression. Heart mitochondrial function was also impaired displaying more protein oxidation and less activity for IV, respectively, than no-treated mice. In addition, a significant reduction in the protein expression levels of Mitofusin 2 and Voltage-Dependent Anion Carrier was observed. All these results suggest that quercetin affects erythropoiesis and mitochondrial function and then its potential use as a dietary supplement should be reexamined.- 1 January 2015
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2015, 1-12
Open AccessQuercetin Affects Erythropoiesis and Heart Mitochondrial Function in Mice
Quercetin, a dietary flavonoid used as a food supplement, showed powerful antioxidant effects in different cellular models. However, recentin vitroandin vivostudies in mammals have suggested a prooxidant effect of quercetin and described an interaction with mitochondria causing an increase inproduction, a decrease in ATP levels, and impairment of respiratory chain in liver tissue. Therefore, because of its dual actions, we studied the effect of quercetinin vivoto analyze heart mitochondrial function and erythropoiesis. Mice were injected with 50 mg/kg of quercetin for 15 days. Treatment with quercetin decreased body weight, serum insulin, and ceruloplasmin levels as compared with untreated mice. Along with an impaired antioxidant capacity in plasma, quercetin-treated mice showed a significant delay on erythropoiesis progression. Heart mitochondrial function was also impaired displaying more protein oxidation and less activity for IV, respectively, than no-treated mice. In addition, a significant reduction in the protein expression levels of Mitofusin 2 and Voltage-Dependent Anion Carrier was observed. All these results suggest that quercetin affects erythropoiesis and mitochondrial function and then its potential use as a dietary supplement should be reexamined.